U.S. Markets
Hims & Hers Health Inc. (HIMS) Q1 2026 (USD): EPS -0.40 (exp. 0.04), Revenue 608mln (exp. 617mln)
News detail
Guidance: Q2 adj. EBITDA 35-55mln (exp. 70.1mln). Q2 revenue 680-700mln (exp. 643mln). FY adj. EBITDA 275-300mln (exp. 322.8mln). FY revenue 2.8-3bln (exp. 2.75bln)
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
